Literature DB >> 8314434

Mortality trends and causes of death in diabetic patients.

J H Fuller1.   

Abstract

Although national mortality statistics for diabetes mellitus are often quoted in the literature, problems with their validation need to be overcome. They are based upon the assignment of diabetes as the so-called "underlying cause of death", which has several limitations when applied to studies of diabetes mortality. The EURODIAB Sub-Area C study group has carried out simulation studies which indicate that European variations in physicians' certifying practices and national coding procedures could explain about 35% of the variation in published European mortality rates for diabetes. Some of these problems can be overcome by the use of a "multiple-cause" encoding procedure which is recommended for monitoring of the targets of the St Vincent Declaration Action Programme for Europe. Studies of specific causes of death in cohorts of subjects with insulin-dependent diabetes mellitus indicate that many of these premature deaths are potentially avoidable. The major cause of death in patients with non-insulin-dependent diabetes continues to be cardiovascular disease. Studies in England and Wales indicate the diabetic patients are not experiencing the same fall in cardiovascular mortality as that experienced by the general population.

Entities:  

Mesh:

Year:  1993        PMID: 8314434

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  5 in total

1.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

Review 2.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Evaluating the terminology requirements to support multi-disciplinary diabetes care.

Authors:  P J Brown; C Price; P H Sonksen
Journal:  Proc AMIA Annu Fall Symp       Date:  1997

4.  The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus.

Authors:  Ogbera A Okeoghene; Azenabor Alfred
Journal:  Indian J Endocrinol Metab       Date:  2013-01

5.  Burden attributable to Cardiometabolic Diseases in Zimbabwe: a retrospective cross-sectional study of national mortality data.

Authors:  Mutsa P Mutowo; Alice J Owen; Baki Billah; Paula K Lorgelly; Kudzai E Gumbie; John C Mangwiro; Andre M N Renzaho
Journal:  BMC Public Health       Date:  2015-12-07       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.